Rossari Biotech Ltd.

₹506

1.7 (0.3%)

ROSSARI Share Price

Chemicals & Petrochemicals

As on July 29, 2026

SectorChemicals

IndustryChemicals & Petrochemicals

Basic IndustrySpecialty Chemicals

Market Cap₹ 2,828 Cr

P/E Ratio18.78

Dividend Yield0.05 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	502.4	Bullish
10-DMA	511.25	Bearish
20-DMA	517.26	Bearish
50-DMA	521.64	Bearish
100-DMA	494.12	Bullish
200-DMA	539.06	Bearish

Historical Performance

1 Year

-27.9%

3 Years

-42.2%

5 Years

-59.1%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	23,964	20,803	18,306	16,559	14,830
Total Expenditure	21,273	18,261	15,875	14,413	13,067
Other Income	392	149	141	139	191
Operating Profit	3,083	2,691	2,572	2,285	1,954
Interest	285	178	194	223	127
Depreciation	791	671	604	629	481
Profit Before Tax	2,025	1,852	1,776	1,442	1,363
Consolidated Net Profit	1,492	1,364	1,307	1,073	977
Adjusted EPS	27	25	24	19	18

Compounded Sales Growth

10 Years:68.1

5 Years:27.6

3 Years:7.7

TTM:2.9

Compounded Profit Growth

10 Years:113.2

5 Years:13.2

3 Years:6.8

TTM:1.8

Stock Price CAGR

10 Years:N/A

5 Years:-16.4

3 Years:-16.7

TTM:-27.3

Return on Equity

10 Years:3.3

5 Years:17.7

3 Years:23.7

last year:26.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	111	111	110	110	110
Total Reserves	13,168	11,722	10,331	9,006	7,909
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	3,145	2,615	1,930	1,809	2,514
Other Current Liabilities	1,651	1,552	1,285	1,260	997
Short Term Borrowings	2,837	755	625	290	---
Total Liabilities	26,546	21,874	18,246	15,717	14,168
Capital Work in Progress	1,733	1,402	472	131	13
Long Term Loans & Advances	2,056	1,753	1,705	965	1,087
Currents Investments	351	573	376	260	115
Short Term Loans and Advances	3,586	2,986	2,254	1,520	1,106
Total Current Assets	14,530	12,457	10,028	8,474	6,749
Total Assets	26,546	21,874	18,246	15,717	14,168
Adjusted Book Value	240	214	189	165	146

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 18.78, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a weak 3-year price CAGR of -15.6%, indicating poor shareholder returns.
The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹3083 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹23964 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 727534.1

No. of Shares: 1438 (Approx)

Performance:-27.2%

-272465.9

NIFTY Performance: -2.4%

1 day Top Gainers